FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rebecca Elstrom

Research Profile

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Rebecca L Elstrom
Response assessment in lymphoma: time to lower the bar?
Rebecca L Elstrom
Interim response assessment for Hodgkin lymphoma: size matters.
Rebecca L Elstrom; Biree Andemariam; Morton Coleman; John P Leonard; Peter Martin; Jia Ruan; Tsiporah B Shore; Richard R Furman
Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rebecca Elstrom (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rebecca L Elstrom
Response assessment in lymphoma: time to lower the bar?
Leukemia & lymphoma 2013;54(4):673-4.
2012: Rebecca L Elstrom
Interim response assessment for Hodgkin lymphoma: size matters.
Leukemia & lymphoma 2012;53(11):2095-6.
2012: Rebecca L Elstrom; Biree Andemariam; Morton Coleman; John P Leonard; Peter Martin; Jia Ruan; Tsiporah B Shore; Richard R Furman
Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma.
Leukemia & lymphoma 2012;53(8):1469-73.
2012: Morton Coleman; Rebecca L Elstrom; Peter Martin; Gia Ruan; John P Leonard
Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimen.
Hematology (Amsterdam, Netherlands) 2012;17 Suppl 1():S90-2.
2012: Rebecca L Elstrom; Richard R Furman; Morton Coleman; John P Leonard; Tomer Mark; Peter Martin; Roger N Pearse; Jia Ruan; Tsiporah Shore; Sandra Hurtado Rua; Usama Gergis
Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity.
American journal of hematology 2012;87(4):433-5.
2011: Jia Ruan; Peter Martin; Richard R Furman; Shing M Lee; Ken Cheung; Julie M Vose; Ann S LaCasce; Julia Morrison; Rebecca L Elstrom; Scott Ely; Amy Chadburn; Ethel Cesarman; Morton Coleman; John P Leonard
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(6):690-7.
2010: Richard R Furman; Peter Martin; Jia Ruan; Ying-Kuen K Cheung; Julie M Vose; Ann S LaCasce; Rebecca L Elstrom; Morton Coleman; John P Leonard
Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.
Cancer 2010;116(23):5432-9.
2010: Rebecca L Elstrom; Peter Martin; Katya Ostrow; Jacqueline Barrientos; Amy Chadburn; Richard Furman; Jia Ruan; Tsiporah Shore; Michael Schuster; Leandro Cerchietti; Ari Melnick; Morton Coleman; John P Leonard
Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategies.
Clinical lymphoma, myeloma & leukemia 2010;10(3):192-6.
2010: Jia Ruan; Peter Martin; Morton Coleman; Richard R Furman; Ken Cheung; Adam Faye; Rebecca L Elstrom; Mark Lachs; Katherine A Hajjar; John P Leonard
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.
Cancer 2010;116(11):2655-64.
2009: Peter Martin; Amy Chadburn; Paul J Christos; Karen Weil; Richard R Furman; Jia Ruan; Rebecca L Elstrom; Ruben Niesvizky; Scott Ely; Maurizio Diliberto; Ari Melnick; Daniel M Knowles; Selina Chen-Kiang; Morton Coleman; John P Leonard
Outcome of deferred initial therapy in mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(8):1209-13.
2008: Rebecca L Elstrom; John P Leonard
FDG-PET scans in patients with lymphoma.
Current hematologic malignancy reports 2008;3(4):197-203.
2008: Rebecca L Elstrom; Peter Martin; John P Leonard
New biologic agents and immunologic strategies.
Hematology/oncology clinics of North America 2008;22(5):1037-49, x-xi.
2008: Sarah C Rutherford; Biree Andemariam; Shibu M Philips; Rebecca L Elstrom; Amy Chadburn; Richard R Furman; Ruben Niesvizky; Peter Martin; Thomas J Fahey; Morton Coleman; Stanley J Goldsmith; John P Leonard
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma.
Leukemia & lymphoma 2008;49(4):719-26.
2008: Morton Coleman; Peter Martin; Jia Ruan; Richard R Furman; Ruben Niesvizky; Rebecca L Elstrom; Patricia George; John Leonard; Thomas Kaufmann
Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma.
Leukemia & lymphoma 2008;49(3):447-50.
2007: Michele R Roullet; Rachel Sargent; Theresa Pasha; Isabela Cajiao; Rebecca L Elstrom; Treasa Smith; Stephen A Liebhaber; Paul Zhang; Adam Bagg
ZAP70 expression assessed by immunohistochemistry on peripheral blood: a simple prognostic assay for patients with chronic lymphocytic leukemia.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2007;15(4):471-6.
2007: Isabela Cajiao; Rachel Sargent; Rebecca L Elstrom; Nancy E Cooke; Adam Bagg; Stephen A Liebhaber
Igbeta(CD79b) mRNA expression in chronic lymphocytic leukaemia cells correlates with immunoglobulin heavy chain gene mutational status but does not serve as an independent predictor of clinical severity.
American journal of hematology 2007;82(8):712-20.
2006: Lapo Alinari; paolo castellucci; Rebecca L Elstrom; Valentina Ambrosini; Vittorio Stefoni; Cristina Nanni; Arnold Berkowitz; Monica Tani; Mohsen Farsad; Roberto Franchi; Stefano Fanti; Pier Luigi Zinzani
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma.
Leukemia & lymphoma 2006;47(10):2096-101.
2006: Noelle V Frey; Jakub Svoboda; Charalambos Andreadis; Donald E Tsai; Stephen J Schuster; Rebecca L Elstrom; Stephen C Rubin; Sunita D Nasta
Primary lymphomas of the cervix and uterus: the University of Pennsylvania's experience and a review of the literature.
Leukemia & lymphoma 2006;47(9):1894-901.
2006: Jakub Svoboda; Charalambos Andreadis; Rebecca L Elstrom; Elise A Chong; Lisa H Downs; Arnold Berkowitz; Selina M Luger; David Porter; Sunita D Nasta; Donald Tsai; Alison W Loren; Don L Siegel; Eli Glatstein; Abass Alavi; Edward A Stadtmauer; Stephen J Schuster
Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation.
Bone marrow transplantation 2006;38(3):211-6.
2006: Rebecca L Elstrom; Charalambos Andreadis; Nicole A Aqui; Vivek N Ahya; Roy D Bloom; Susan C Brozena; Kim M Olthoff; Stephen J Schuster; Sunita D Nasta; Edward A Stadtmauer; Donald E Tsai
Treatment of PTLD with rituximab or chemotherapy.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6(3):569-76.
2005: Charalambos Andreadis; Stephen J Schuster; Elise A Chong; Jakub Svoboda; Selina M Luger; David Porter; Donald E Tsai; Sunita D Nasta; Rebecca L Elstrom; Steven C Goldstein; Lisa H Downs; Patricia A Mangan; K A Cunningham; K A Hummel; Phyllis A Gimotty; Don L Siegel; Eli Glatstein; Edward A Stadtmauer
Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma.
Bone marrow transplantation 2005;36(11):955-61.
2005: Dan T Vogl; Eli Glatstein; Joseph R Carver; Stephen J Schuster; Edward A Stadtmauer; Selina M Luger; Sunita D Nasta; David Porter; Rebecca L Elstrom; Donald E Tsai
Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation.
Leukemia & lymphoma 2005;46(9):1313-20.
2005: Monica Buzzai; Daniel E Bauer; Russell G Jones; Ralph J DeBerardinis; Georgia Hatzivassiliou; Rebecca L Elstrom; Craig Thompson
The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation.
Oncogene 2005;24(26):4165-73.
2004: Rebecca L Elstrom; Donald E Tsai; Jo-Anne Vergilio; Lisa H Downs; Abass Alavi; Stephen J Schuster
Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow.
Clinical lymphoma 2004;5(1):62-4.
2004: Rebecca L Elstrom; Daniel E Bauer; Monica Buzzai; Robyn Karnauskas; Marian H Harris; David Plas; Hongming Zhuang; Ryan M Cinalli; Abass Alavi; Charles Rudin; Craig Thompson
Akt stimulates aerobic glycolysis in cancer cells.
Cancer research 2004;64(11):3892-9.
2003: Jeffrey C Rathmell; Rebecca L Elstrom; Ryan M Cinalli; Craig Thompson
Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma.
European journal of immunology 2003;33(8):2223-32.
2003: Rebecca L Elstrom; Liang Guan; Gary Baker; Khozaim Nakhoda; Jo-Anne Vergilio; Hongming Zhuang; Stephanie Pitsilos; Adam Bagg; Lisa H Downs; Amit Mehrotra; Scott Kim; Abass Alavi; Stephen J Schuster
Utility of FDG-PET scanning in lymphoma by WHO classification.
Blood 2003;101(10):3875-6.
2002: Kenneth A Frauwirth; James L Riley; Marian H Harris; Richard V Parry; Jeffrey C Rathmell; David Plas; Rebecca L Elstrom; Carl H June; Craig Thompson
The CD28 signaling pathway regulates glucose metabolism.
Immunity 2002;16(6):769-77.